DARE Bathi saben saham sajrone rolas wulan pungkasan Dare Bioscience Inc.

Dare Bioscience, Inc. (DARE) develops advanced therapeutic solutions for women. The rolling annual earnings per share value demonstrates capital management efficiency, where the -0.80 metric reflects the current figure. Dare Bioscience, Inc. (DARE) is developing partnerships with global pharma behemoths for joint research. The strategy relies on expanding the product portfolio and B2B licensing. Operations are conducted within a stable US legal framework without geopolitical risks.

DARE (Dare Bioscience, Inc.) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 12.11.2026

Rincian metrik keuangan lan pasar Dare Bioscience (DARE)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Dare Bioscience, Inc.|DARE - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Dare Bioscience|DARE - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Buku saben Saham Daré Bioscience|DARE - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku darebioscience.com|DARE - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Dare Bioscience, Inc.|DARE - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Dare Bioscience Inc.|DARE - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Dare Bioscience|DARE - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Daré Bioscience|Indikator likuiditas cepet darebioscience.com

- indikator pendapatan resik lan kelipatan nilai:

DARE - Bathi pungkasan|Proyeksi bathi mangsa ngarep Dare Bioscience, Inc.|DARE - Rasio rega marang bathi|Pangali Forward P/E Daré Bioscience|DARE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Dare Bioscience|DARE - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Daré Bioscience|DARE - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan darebioscience.com|DARE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Dare Bioscience, Inc.

Analisis kabeh metrik perusahaan:DARE - Dare Bioscience, Inc.

Operational business resilience is determined by the ability to generate real income per share of capital. This indicator is calculated as the ratio of net income over a rolling year to the total number of shares, measuring the actual efficiency of resource allocation. For Dare Bioscience, Inc. (DARE), this parameter reflects the financial transition from R&D expenditures to profits from gel sales. The dynamics of commercial scaling through global partners directly impact the TTM net income per share metric. Analysis of this chart allows for an assessment of the company's pace toward reaching the break-even point.

Perusahaan pesaing

OGN - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan TherapeuticsMD, Inc.|Palatin Technologies, Inc. (PTN) - Bathi saben saham sajrone rolas wulan pungkasan